Also listed in trial records as Apimid, Cebatrol, Chimax
Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 4 trials in our Mexico, Canada, Israel and Switzerland registers that name Flutamide as an intervention.Synced 26 Sep 2026
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov registry records · Last verified · Editorial standards
At a glance
Flutamide is named as an intervention in 4 current clinical trials
in our Mexico, Canada, Israel and Switzerland registers.
1 is recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is NRG Oncology (3). The most-studied condition is Stage IVA Prostate Cancer AJCC v8.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
02
Flutamide across our data
Ireland · EU · US
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
Flutamid AL 250Germany (BfArM) · Other reason · 22 Oct 2025 to 1 Dec 2026
Flutamid AL 250Germany (BfArM) · Other reason · 22 Oct 2025 to 1 Dec 2026
Stage IVA Prostate Cancer AJCC v82Prostate Adenocarcinoma2Castration Levels of Testosterone1Metastatic Prostatic Adenocarcinoma1Stage IV Prostate Cancer AJCC v81Stage III Prostate Cancer AJCC v81Stage I Prostate Adenocarcinoma AJCC v71Stage II Prostate Adenocarcinoma AJCC v71Stage III Prostate Adenocarcinoma AJCC v71
4 current trials in our Mexico, Canada, Israel and Switzerland registers name Flutamide as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Are Flutamide trials recruiting patients?
Yes. 1 of the 4 trials is recruiting: 1 with sites in Mexico and 1 with sites in Switzerland. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Flutamide clinical trials?
NRG Oncology (3) and SWOG Cancer Research Network (1). The number in brackets is how many trials each organisation leads.
Is there a Flutamide shortage?
The registers we track list 2 entries for Flutamide: 2 German notices. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Flutamide works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Flutamide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Flutamide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.
Please verify before you rely on this.
This page is general information for life-science and pharmaceutical professionals. It is
not medical advice, and it has not been reviewed by a clinician — our editorial
team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most
recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC)
and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not
automatically interchangeable, and approvals, brand names and indications differ between the US, the
EU/Ireland (EMA/HPRA) and other regions.
Spotted an error? Tell us — we correct promptly and log it.
We value your privacy
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.